SEMAX 10

Semax was developed in the Russian Academy of Medical Sciences and has been studied extensively in Russia and surrounding countries. It’s classified as a nootropic and neuroprotective agent with unique effects on the central nervous system.

Key Research-Based Benefits of Semax:

1.  Neuroprotection

• Studies in stroke patients show that Semax can protect brain cells from damage due to lack of oxygen (hypoxia) or trauma.
• It reduces oxidative stress, which helps slow down damage to the nervous system.
• [Study highlight]: Patients given Semax after ischemic stroke had better recovery outcomes and reduced brain inflammation.

2.  Cognitive Enhancement

• Improves attention, memory, and learning in both healthy individuals and those with cognitive disorders.
• It increases brain-derived neurotrophic factor (BDNF) — a protein that supports the growth and survival of neurons.
• In animal studies, Semax enhanced memory in stressful and aging conditions.

3. Mood and Stress Regulation

• Semax affects dopamine and serotonin systems — the same systems targeted by many antidepressants.
• In trials, it showed anti-anxiety and antidepressant effects without sedating the person.
• Useful in treating depression, anxiety, and mental fatigue, especially during recovery from illness.

4.  Mental Energy and Focus

• Used in high-performance, high-stress environments (like pilots, surgeons, and athletes) to maintain clarity and reaction time.
• May be helpful for people with ADHD or those dealing with brain fog.

5. Anti-inflammatory and Immune Modulation

• Semax has been shown to balance immune responses and reduce inflammation.
• Potential applications in autoimmune disorders, chronic fatigue, and post-viral syndromes.

How Semax Works (Mechanism of Action):

• Boosts BDNF levels (supports neuron repair and growth)
• Modulates dopamine, serotonin, and other neurotransmitters
• Reduces inflammation in brain tissue
• Improves oxygen delivery and blood flow in the brain

Summary of Clinical Uses (in Research & Off-label):